Literature DB >> 33229065

A five-year cohort study on testicular tumors from a population-based canine cancer registry in central Italy (Umbria).

Elisabetta Manuali1, Claudio Forte2, Ilaria Porcellato3, Chiara Brachelente4, Monica Sforna4, Silvia Pavone1, Saverio Ranciati5, Raffaello Morgante1, Ines Maria Crescio6, Giuseppe Ru6, Luca Mechelli4.   

Abstract

Canine testicular tumors account for about 90 % of tumors affecting the male genitalia. Seminomas (SEM), Sertoli cell tumors (SCT), and interstitial cell tumors (ICT) are the most common histological diagnoses, but their incidence shows high variability among studies. Our aim is to report the results on the analysis of testicular tumors recorded by the population-based Umbria Canine Cancer Registry (CCR) for a 5-year time period and to assess the value of tumor major diameter, measured during trimming, in discriminating neoplastic from non-neoplastic lesions. The study was conducted on 388 testicular tumors (on 1969 total male tumors) diagnosed in 355 dogs from 2014 to 2018. The median incidence was 35 cases/100,000 dogs, with a proportion equal to 19,7 % of all tumors. The incidence on neutered male dogs was 352/100,000. Most tumors were ICTs (50 %), with fewer SEMs and SCTs (29 % and 17 %, respectively). Only 3 % of tumors were mixed germ cell-sex cord-stromal tumors (MGC-SCST). Ten percent of cases had multiple tumors in the same testicle, with SEM-ICT being prevalent (69.2 %). Tumors in cryptorchid testes were 5.9 % of the total, mostly SCT (60.9 %). Mean age at diagnosis was 10.7 ± 2.7, with similar values for different tumor types. Significant incidence ratios (IRR) were found in Golden retriever (IRR 7.18, CI95 % 4.72-10.92) and in English cocker spaniel (IRR 2.30, CI95 % 1.28-4.13) when compared with mixed breed dogs. A value of 0.3 cm (major diameter) of lesions at the moment of trimming was helpful in discriminating a final tumor histological diagnosis from a non-tumor lesion. Since the number of tumors included in this evaluation was limited, further studies to confirm the diagnostic value of this measure are recommended. Our results provided information on the incidence of canine testicular tumors in Umbria region that can be compared with future results and incidence from other geographical areas if provided with reliable data on the total population, can offer solid information on the incidence and proportion of different tumor types in specific territories, contributing also to the supervision of its inhabitants' health. Moreover, pathological data such as the major diameter of tumors can be obtained and contribute to diagnostic routine and standardization.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine Cancer Registry; Dogs; Incidence; Risk factors; Testicular neoplasms

Mesh:

Year:  2020        PMID: 33229065     DOI: 10.1016/j.prevetmed.2020.105201

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  3 in total

1.  Large scale across-breed genome-wide association study reveals a variant in HMGA2 associated with inguinal cryptorchidism risk in dogs.

Authors:  Matthew Blades; Jamie Freyer; Jonas Donner; Rebecca Chodroff Foran; Oliver P Forman
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

2.  Canine testicular tumors: An 11-year retrospective study of 358 cases in Moscow Region, Russia.

Authors:  Aleksey A Gazin; Yury A Vatnikov; Nikolay V Sturov; Evgeny V Kulikov; Viktor Grishin; Elena A Krotova; Alisa A Razumova Varentsova; Natalia Yu Rodionova Sapego; Natalia I Troshina; Varvara M Byakhova; Ksenia V Lisitskaya
Journal:  Vet World       Date:  2022-02-26

3.  Cross Species Analysis and Comparison of Tumors in Dogs and Cats, by Age, Sex, Topography and Main Morphologies. Data from Vet-OncoNet.

Authors:  Katia Pinello; Isabel Pires; Ana Filipa Castro; Paulo Tiago Carvalho; Andreia Santos; Augusto de Matos; Felisbina Queiroga; Ana Canadas-Sousa; Patrícia Dias-Pereira; José Catarino; Pedro Faísca; Sandra Branco; Cristiana Lopes; Filipa Marcos; Maria C Peleteiro; Hugo Pissarra; Pedro Ruivo; Rui Magalhães; Milton Severo; João Niza-Ribeiro
Journal:  Vet Sci       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.